Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer.
Ritaparna AhmedLeyder Elena LozanoAmandine AnastasioSebastien LofekBeatris Mastelic-GavilletBlanca Navarro RodrigoSylvain NguyenFlorence DartiguenaveSonia-Cristina Rodrigues-DiasValérie CessonMassimo ValérioBeat RothLana Elias KandalaftIrina RedchenkoAdrian Vivian Sinton HillAlexandre HarariPedro RomeroLaurent DerréSelena ViganóPublished in: Cancers (2023)
Benign prostate hyperplasia (BPH) is a frequent condition in aging men, which affects life quality, causing principally lower urinary tract symptoms. Epidemiologic studies suggest that BPH may raise the risk of developing prostate cancer (PCa), most likely promoting a chronic inflammatory environment. Studies aiming at elucidating the link and risk factors that connect BPH and PCa are urgently needed to develop prevention strategies. The BPH microenvironment, similar to the PCa one, increases immune infiltration of the prostate, but, in contrast to PCa, immunosuppression may not be established yet. In this study, we found that prostate-infiltrating lymphocytes (PILs) expanded from hyperplastic prostate tissue recognized tumor-associated antigens (TAA) and autologous tissue, regardless of the presence of tumor cells. PILs expanded from BPH samples of patients with PCa, however, seem to respond more strongly to autologous tissue. Phenotypic characterization of the infiltrating PILs revealed a trend towards better expanding CD4 + T cells in infiltrates derived from PCa, but no significant differences were found. These findings suggest that T cell tolerance is compromised in BPH-affected prostates, likely due to qualitative or quantitative alterations of the antigenic landscape. Our data support the hypothesis that BPH increases the risk of PCa and may pave the way for new personalized preventive vaccine strategies for these patients.
Keyphrases
- benign prostatic hyperplasia
- lower urinary tract symptoms
- prostate cancer
- risk factors
- radical prostatectomy
- bone marrow
- end stage renal disease
- gene expression
- newly diagnosed
- magnetic resonance
- oxidative stress
- cell therapy
- peripheral blood
- chronic kidney disease
- single cell
- systematic review
- magnetic resonance imaging
- computed tomography
- platelet rich plasma
- prognostic factors
- high resolution
- big data
- electronic health record
- patient reported outcomes
- mesenchymal stem cells
- deep learning
- middle aged
- data analysis
- drug induced
- patient reported